Revium Rx (RVRC) Total Current Liabilities (2024 - 2026)

Revium Rx (RVRC) posted Total Current Liabilities of $1.4 million for Q4 2025, up 137.67% sequentially from $576000.0 in Q4 2024, and up 137.67% YoY from $576000.0 in Q4 2024.

Revium Rx (RVRC) Total Current Liabilities (2024 - 2026) Analysis & Trends

Revium Rx has reported Total Current Liabilities for 2 years, with the latest figure at $1.4 million in Q4 2025.

  • Quarterly Total Current Liabilities rose 137.67% year-over-year to $1.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 137.67% YoY) and the FY2025 annual result came in at $1.4 million, up 137.67% from the prior year.
  • Total Current Liabilities improved to $1.4 million in Q4 2025 per RVRC's latest filing, from $576000.0 in the prior quarter.
  • Over five years, Total Current Liabilities peaked at $1.4 million in Q4 2025 and troughed at $576000.0 in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Veeva Systems 39.72 Bn 32.40 Bn 662.02 Mn 1.70 Bn
2 BrightSpring Health Services 12.19 Bn 11.64 Bn 492.75 Mn 1.56 Bn
3 Healthequity 8.79 Bn 8.52 Bn 256.31 Mn 135.74 Mn
4 10x Genomics 7.31 Bn 6.76 Bn 112.50 Mn 118.51 Mn
5 Hinge Health 7.10 Bn 6.71 Bn 183.95 Mn 481.44 Mn
6 MiniMed 5.66 Bn 5.36 Bn 480.00 Mn 702.00 Mn
7 Waystar Holding 4.76 Bn 4.56 Bn 221.99 Mn 237.72 Mn
8 Doximity 4.46 Bn 3.77 Bn 132.93 Mn 150.36 Mn
9 Heartflow 3.66 Bn 3.28 Bn 53.19 Mn 44.09 Mn
10 Revium Rx 101.42 Mn 99.91 Mn - 971,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 971,000.00
Dec 31, 2025 1.37 Mn
Dec 31, 2024 576,000.00